Nichols KE - Search Results

1

Analysis of the Li-Fraumeni Spectrum Based on an International Germline TP53 Variant Data Set: An International Agency for Research on Cancer TP53 Database Analysis.

Kratz CP, Freycon C, Maxwell KN, Nichols KE, Schiffman JD, Evans DG, Achatz MI, Savage SA, Weitzel JN, Garber JE, Hainaut P, Malkin D. Kratz CP, et al. Among authors: nichols ke. JAMA Oncol. 2021 Dec 1;7(12):1800-1805. doi: 10.1001/jamaoncol.2021.4398. JAMA Oncol. 2021. PMID: 34709361 Free PMC article.

2

Prevalence of germline truncating mutations in ATM in women with a second breast cancer after radiation therapy for a contralateral tumor.

Shafman TD, Levitz S, Nixon AJ, Gibans LA, Nichols KE, Bell DW, Ishioka C, Isselbacher KJ, Gelman R, Garber J, Harris JR, Haber DA. Shafman TD, et al. Among authors: nichols ke. Genes Chromosomes Cancer. 2000 Feb;27(2):124-9. Genes Chromosomes Cancer. 2000. PMID: 10612799

3

Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers.

Nichols KE, Malkin D, Garber JE, Fraumeni JF Jr, Li FP. Nichols KE, et al. Cancer Epidemiol Biomarkers Prev. 2001 Feb;10(2):83-7. Cancer Epidemiol Biomarkers Prev. 2001. PMID: 11219776

4

Destabilization of CHK2 by a missense mutation associated with Li-Fraumeni Syndrome.

Lee SB, Kim SH, Bell DW, Wahrer DC, Schiripo TA, Jorczak MM, Sgroi DC, Garber JE, Li FP, Nichols KE, Varley JM, Godwin AK, Shannon KM, Harlow E, Haber DA. Lee SB, et al. Among authors: nichols ke. Cancer Res. 2001 Nov 15;61(22):8062-7. Cancer Res. 2001. PMID: 11719428

5

TP53, BRCA1, and BRCA2 tumor suppressor genes are not commonly mutated in survivors of Hodgkin's disease with second primary neoplasms.

Nichols KE, Heath JA, Friedman D, Biegel JA, Ganguly A, Mauch P, Diller L. Nichols KE, et al. J Clin Oncol. 2003 Dec 15;21(24):4505-9. doi: 10.1200/JCO.2003.12.042. J Clin Oncol. 2003. PMID: 14673037

6

A common molecular mechanism underlies two phenotypically distinct 17p13.1 microdeletion syndromes.

Shlien A, Baskin B, Achatz MI, Stavropoulos DJ, Nichols KE, Hudgins L, Morel CF, Adam MP, Zhukova N, Rotin L, Novokmet A, Druker H, Shago M, Ray PN, Hainaut P, Malkin D. Shlien A, et al. Among authors: nichols ke. Am J Hum Genet. 2010 Nov 12;87(5):631-42. doi: 10.1016/j.ajhg.2010.10.007. Am J Hum Genet. 2010. PMID: 21056402 Free PMC article.

7

Identification, management, and evaluation of children with cancer-predisposition syndromes.

Knapke S, Zelley K, Nichols KE, Kohlmann W, Schiffman JD. Knapke S, et al. Among authors: nichols ke. Am Soc Clin Oncol Educ Book. 2012:576-84. doi: 10.14694/EdBook_AM.2012.32.8. Am Soc Clin Oncol Educ Book. 2012. PMID: 24451799 Free article.

8

Predisposition to pediatric and hematologic cancers: a moving target.

Malkin D, Nichols KE, Zelley K, Schiffman JD. Malkin D, et al. Among authors: nichols ke. Am Soc Clin Oncol Educ Book. 2014:e44-55. doi: 10.14694/EdBook_AM.2014.34.e44. Am Soc Clin Oncol Educ Book. 2014. PMID: 24857136 Free article. Review.

9

Parent decision-making around the genetic testing of children for germline TP53 mutations.

Alderfer MA, Zelley K, Lindell RB, Novokmet A, Mai PL, Garber JE, Nathan D, Scollon S, Chun NM, Patenaude AF, Ford JM, Plon SE, Schiffman JD, Diller LR, Savage SA, Malkin D, Ford CA, Nichols KE. Alderfer MA, et al. Among authors: nichols ke. Cancer. 2015 Jan 15;121(2):286-93. doi: 10.1002/cncr.29027. Epub 2014 Sep 15. Cancer. 2015. PMID: 25223899 Free article.

10

Genotype Versus Phenotype: The Yin and Yang of Germline TP53 Mutations in Li-Fraumeni Syndrome.

Nichols KE, Malkin D. Nichols KE, et al. J Clin Oncol. 2015 Jul 20;33(21):2331-3. doi: 10.1200/JCO.2015.61.5757. Epub 2015 Jun 22. J Clin Oncol. 2015. PMID: 26101242 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

269 results

Search Page